Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Feb;93(2):247–256. doi: 10.1111/j.1476-5381.1988.tb11428.x

Anticonvulsant effects of some calcium entry blockers in DBA/2 mice.

G B De Sarro 1, B S Meldrum 1, G Nisticó 1
PMCID: PMC1853817  PMID: 3359104

Abstract

1. The behavioural and anticonvulsant effects of several drugs acting by various mechanisms on calcium-channels or affecting intracellular Ca2+ concentrations were studied after both systemic and intracerebroventricular administration in DBA/2 mice, a strain genetically susceptible to sound-induced seizures. 2. The anticonvulsant effects were evaluated on seizures evoked by means of auditory stimulation (109 dB) in animals placed singly under a perspex dome. 3. Flunarizine and dihydropyridine derivatives, belonging to class I of calcium entry blockers, administered intraperitoneally, were the most potent compounds. 4. Diltiazem, a benzothiazepine derivative belonging to class III, and HA 1004, a calcium antagonist, acting by inhibiting Ca2+ mobilization from intracellular stores, injected intraperitoneally, were 3-7.6 fold and 5.8-10.7 fold less potent than flunarizine respectively. 5. Verapamil and methoxyverapamil, two phenylalkylamine derivatives, given intraperitoneally, were completely ineffective in preventing sound-induced seizures in DBA/2 mice. In addition, high doses of verapamil and its methoxyderivative occasionally produced spontaneous tonic-clonic seizures. 6. After intracerebroventricular administration of the hydrosoluble calcium entry blockers, belonging to different classes, the anticonvulsant effects were similar to those observed after systemic administration. 7. The systemic administration of Bay K 8644, a dihydropyridine analogue, having the ability to stimulate calcium entry into cells produced a dose-dependent increase in clonic and tonic convulsions and other neurological side effects. 8. The present results strongly support the idea that some Ca2+ antagonists may be useful in human epilepsy.

Full text

PDF
247

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan R. D., Dickenson H. W., Hiern B. P., Johnston G. A., Kazlauskas R. Isothiouronium compounds as gamma-aminobutyric acid agonists. Br J Pharmacol. 1986 Jun;88(2):379–387. doi: 10.1111/j.1476-5381.1986.tb10214.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Asano M., Hidaka H. Pharmacological properties of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), a calmodulin antagonist in arterial strips from rats and rabbits. J Pharmacol Exp Ther. 1985 Aug;234(2):476–484. [PubMed] [Google Scholar]
  3. Ashton D., Wauquier A. Effects of some anti-epileptic, neuroleptic and gabaminergic drugs on convulsions induced by D,L-allylglycine. Pharmacol Biochem Behav. 1979 Aug;11(2):221–226. doi: 10.1016/0091-3057(79)90017-0. [DOI] [PubMed] [Google Scholar]
  4. Bolger G. T., Weissman B. A., Skolnick P. The behavioral effects of the calcium agonist Bay K 8644 in the mouse: antagonism by the calcium antagonist nifedipine. Naunyn Schmiedebergs Arch Pharmacol. 1985 Feb;328(4):373–377. doi: 10.1007/BF00692903. [DOI] [PubMed] [Google Scholar]
  5. Brown A. M., Kunze D. L., Yatani A. The agonist effect of dihydropyridines on Ca channels. Nature. 1984 Oct 11;311(5986):570–572. doi: 10.1038/311570a0. [DOI] [PubMed] [Google Scholar]
  6. Chapman A. G., Croucher M. J., Meldrum B. S. Anticonvulsant activity of intracerebroventricularly administered valproate and valproate analogues. A dose-dependent correlation with changes in brain aspartate and GABA levels in DBA/2 mice. Biochem Pharmacol. 1984 May 1;33(9):1459–1463. doi: 10.1016/0006-2952(84)90413-1. [DOI] [PubMed] [Google Scholar]
  7. Chapman A. G., Croucher M. J., Meldrum B. S. Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures. Arzneimittelforschung. 1984;34(10):1261–1264. [PubMed] [Google Scholar]
  8. Chapman A. G., Meldrum B. S., Mendes E. Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate content. Life Sci. 1983 Apr 25;32(17):2023–2031. doi: 10.1016/0024-3205(83)90054-1. [DOI] [PubMed] [Google Scholar]
  9. Croucher M. J., Collins J. F., Meldrum B. S. Anticonvulsant action of excitatory amino acid antagonists. Science. 1982 May 21;216(4548):899–901. doi: 10.1126/science.7079744. [DOI] [PubMed] [Google Scholar]
  10. Croucher M. J., Meldrum B. S., Collins J. F. Anticonvulsant and proconvulsant properties of a series of structural isomers of piperidine dicarboxylic acid. Neuropharmacology. 1984 Apr;23(4):467–472. doi: 10.1016/0028-3908(84)90257-0. [DOI] [PubMed] [Google Scholar]
  11. Croucher M. J., Meldrum B. S., Krogsgaard-Larsen P. Anticonvulsant activity of GABA uptake inhibitors and their prodrugs following central or systemic administration. Eur J Pharmacol. 1983 May 6;89(3-4):217–228. doi: 10.1016/0014-2999(83)90497-1. [DOI] [PubMed] [Google Scholar]
  12. De Sarro G. B., Croucher M. J., Meldrum B. S. Anticonvulsant actions of DS 103-282. Pharmacological studies in rodents and the baboon, Papio papio. Neuropharmacology. 1984 May;23(5):525–530. doi: 10.1016/0028-3908(84)90025-x. [DOI] [PubMed] [Google Scholar]
  13. De Sarro G. B., Nistico G., Meldrum B. S. Anticonvulsant properties of flunarizine on reflex and generalized models of epilepsy. Neuropharmacology. 1986 Jul;25(7):695–701. doi: 10.1016/0028-3908(86)90084-5. [DOI] [PubMed] [Google Scholar]
  14. DeLorenzo R. J., Burdette S., Holderness J. Benzodiazepine inhibition of the calcium-calmodulin protein kinase system in brain membrane. Science. 1981 Jul 31;213(4507):546–549. doi: 10.1126/science.6264605. [DOI] [PubMed] [Google Scholar]
  15. Desmedt L. K., Niemegeers C. J., Janssen P. A. Anticonvulsive properties of cinnarizine and flunarizine in rats and mice. Arzneimittelforschung. 1975 Sep;25(9):1408–1413. [PubMed] [Google Scholar]
  16. Doran A. R., Narang P. K., Meigs C. Y., Wolkowitz O. M., Roy A., Breier A., Pickar D. Verapamil concentrations in cerebrospinal fluid after oral administration. N Engl J Med. 1985 May 9;312(19):1261–1262. [PubMed] [Google Scholar]
  17. Ferrendelli J. A., Daniels-McQueen S. Comparative actions of phenytoin and other anticonvulsant drugs on potassium- and veratridine-stimulated calcium uptake in synaptosomes. J Pharmacol Exp Ther. 1982 Jan;220(1):29–34. [PubMed] [Google Scholar]
  18. Ferry D. R., Glossmann H. Evidence of multiple receptor sites within the putative calcium channel. Naunyn Schmiedebergs Arch Pharmacol. 1982 Oct;321(1):80–83. doi: 10.1007/BF00586355. [DOI] [PubMed] [Google Scholar]
  19. Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977;17:149–166. doi: 10.1146/annurev.pa.17.040177.001053. [DOI] [PubMed] [Google Scholar]
  20. Godfraind T. Mechanisms of action of calcium entry blockers. Fed Proc. 1981 Dec;40(14):2866–2871. [PubMed] [Google Scholar]
  21. Greenberg D. A., Cooper E. C., Carpenter C. L. Phenytoin interacts with calcium channels in brain membranes. Ann Neurol. 1984 Nov;16(5):616–617. doi: 10.1002/ana.410160514. [DOI] [PubMed] [Google Scholar]
  22. Holmes B., Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs. 1984 Jan;27(1):6–44. doi: 10.2165/00003495-198427010-00002. [DOI] [PubMed] [Google Scholar]
  23. Horton R. W., Collins J. F., Anlezark G. M., Meldrum B. S. Convulsant and anticonvulsant actions in DBA/2 mice of compounds blocking the reuptake of GABA. Eur J Pharmacol. 1979 Oct 26;59(1-2):75–83. doi: 10.1016/0014-2999(79)90026-8. [DOI] [PubMed] [Google Scholar]
  24. Johansen J., Taft W. C., Yang J., Kleinhaus A. L., DeLorenzo R. J. Inhibition of Ca2+ conductance in identified leech neurons by benzodiazepines. Proc Natl Acad Sci U S A. 1985 Jun;82(11):3935–3939. doi: 10.1073/pnas.82.11.3935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jones A. W., Croucher M. J., Meldrum B. S., Watkins J. C. Suppression of audiogenic seizures in DBA/2 mice by two new dipeptide NMDA receptor antagonists. Neurosci Lett. 1984 Mar 23;45(2):157–161. doi: 10.1016/0304-3940(84)90092-2. [DOI] [PubMed] [Google Scholar]
  26. Kazda S., Garthoff B., Meyer H., Schlossmann K., Stoepel K., Towart R., Vater W., Wehinger E. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552). Arzneimittelforschung. 1980;30(12):2144–2162. [PubMed] [Google Scholar]
  27. Meldrum B. S., Croucher M. J., Badman G., Collins J. F. Antiepileptic action of excitatory amino acid antagonists in the photosensitive baboon, Papio papio. Neurosci Lett. 1983 Aug 19;39(1):101–104. doi: 10.1016/0304-3940(83)90172-6. [DOI] [PubMed] [Google Scholar]
  28. Meldrum B. S., Croucher M. J., Czuczwar S. J., Collins J. F., Curry K., Joseph M., Stone T. W. A comparison of the anticonvulsant potency of (+/-) 2-amino-5-phosphonopentanoic acid and (+/-) 2-amino-7-phosphonoheptanoic acid. Neuroscience. 1983 Aug;9(4):925–930. doi: 10.1016/0306-4522(83)90281-6. [DOI] [PubMed] [Google Scholar]
  29. Mendelson W. B., Skolnic P., Martin J. V., Luu M. D., Wagner R., Paul S. M. Diazepam-stimulated increases in the synaptosomal uptake of 45Ca2+: reversal by dihydropyridine calcium channel antagonists. Eur J Pharmacol. 1984 Sep 3;104(1-2):181–183. doi: 10.1016/0014-2999(84)90388-1. [DOI] [PubMed] [Google Scholar]
  30. Overweg J., Binnie C. D., Meijer J. W., Meinardi H., Nuijten S. T., Schmaltz S., Wauquier A. Double-blind placebo-controlled trial of flunarizine as add-on therapy in epilepsy. Epilepsia. 1984 Apr;25(2):217–222. doi: 10.1111/j.1528-1157.1984.tb04178.x. [DOI] [PubMed] [Google Scholar]
  31. Rotiroti D., de Sarro G. B., Musolino R., Nisticò G. A new model of experimental epilepsy: the cefazolin-induced epilepsy. Prog Clin Biol Res. 1983;124:129–144. [PubMed] [Google Scholar]
  32. Sohn R. S., Ferrendelli J. A. Anticonvulsant drug mechanisms. Phenytoin, phenobarbital, and ethosuximide and calcium flux in isolated presynaptic endings. Arch Neurol. 1976 Sep;33(9):626–629. doi: 10.1001/archneur.1976.00500090032006. [DOI] [PubMed] [Google Scholar]
  33. Taft W. C., DeLorenzo R. J. Micromolar-affinity benzodiazepine receptors regulate voltage-sensitive calcium channels in nerve terminal preparations. Proc Natl Acad Sci U S A. 1984 May;81(10):3118–3122. doi: 10.1073/pnas.81.10.3118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wauquier A., Ashton D., Melis W. Behavioral analysis of amygdaloid kindling in beagle dogs and the effects of clonazepam, diazepam, phenobarbital, diphenylhydantoin, and flunarizine on seizure manifestation. Exp Neurol. 1979 Jun;64(3):579–586. doi: 10.1016/0014-4886(79)90233-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES